Inhibition of ERK and proliferation in NK cell lines by soluble HLA-E released from Japanese encephalitis virus infected cells

Immunology Letters

Volumn 162, Issue 1, 2014, Pages 94-100

  Shwetank, ^a,c   Date, Onkar Sanjay ^a,d   Carbone, Ennio ^b   Manjunath, Ramanathapuram ^a  

^a INDIAN INSTITUTE OF SCIENCE   (India)

^b UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^c PENN STATE COLLEGE OF MEDICINE   (United States)

^d SYNGENE INTERNATIONAL LTD   (India)

Author keywords

Endothelial cells; ERK; JEV; NK; Proliferation; SHLA E

Indexed keywords

GAMMA INTERFERON; HLA E ANTIGEN; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA; MITOGEN ACTIVATED PROTEIN KINASE 1; NATURAL KILLER CELL RECEPTOR NKG2A; THYMIDINE; TUMOR NECROSIS FACTOR ALPHA; HLA ANTIGEN CLASS 1; HLA-E ANTIGEN; MITOGEN ACTIVATED PROTEIN KINASE; NATURAL KILLER CELL LECTIN LIKE RECEPTOR SUBFAMILY C;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CELL SURFACE; CONTROLLED STUDY; ENZYME INHIBITION; HUMAN; HUMAN CELL; IMMUNE EVASION; IMMUNE RESPONSE; JAPANESE ENCEPHALITIS; JAPANESE ENCEPHALITIS VIRUS; MOUSE; NATURAL KILLER CELL; NONHUMAN; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN SECRETION; PROTEIN SYNTHESIS; UPREGULATION; VIRUS SHEDDING; VIRUS STRAIN; BIOSYNTHESIS; CELL LINE; DRUG EFFECTS; GENE EXPRESSION; GENETICS; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; PHOSPHORYLATION; VIROLOGY;

CELL LINE; ENCEPHALITIS VIRUS, JAPANESE; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENE EXPRESSION; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; INTERLEUKIN-2; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY C; PHOSPHORYLATION;

EID: 84908275564     PISSN: 01652478     EISSN: 18790542     Source Type: Journal    
DOI: 10.1016/j.imlet.2014.07.010     Document Type: Article

References (36)

1. Lindenbach B.D., Rice C.M. Molecular biology of flaviviruses. Adv Virus Res 2003, 59:23-61.
2. Heinz F.X., Allison S.L. Structures and mechanisms in flavivirus fusion. Adv Virus Res 2000, 55:231-269.
3. Kurane I. Immune responses to Japanese encephalitis virus. Curr Top Microbiol Immunol 2002, 267:91-103.
4. Halstead S.B., Jacobson J. Japanese encephalitis. Adv Virus Res 2003, 61:103-138.
5. Solomon T., Vaughn D.W. Pathogenesis and clinical features of Japanese encephalitis and West Nile virus infections. Curr Top Microbiol Immunol 2002, 267:171-194.
6. Misra U.K., Kalita J. Overview Japanese encephalitis. Prog Neurobiol 2010, 91:108-120.
7. Shwetank, Date O.S., Kim K.S., Manjunath R. Infection of human endothelial cells by Japanese encephalitis virus: increased expression and release of soluble HLA-E. PLoS ONE 2013, 8:e79197.
8. Vales-Gomez M., Reyburn H.T., Erskine R.A., Lopez-Botet M., Strominger J.L. Kinetics and peptide dependency of the binding of the inhibitory NK receptor CD94/NKG2-A and the activating receptor CD94/NKG2-C to HLA-E. EMBO J 1999, 18:4250-4260.
9. Borrego F., Ulbrecht M., Weiss E.H., Coligan J.E., Brooks A.G. Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis. J Exp Med 1998, 187:813-818.
10. Yu T.K., Caudell E.G., Smid C., Grimm E.A. IL-2 activation of NK cells: involvement of MKK1/2/ERK but not p38 kinase pathway. J Immunol 2000, 164:6244-6251.
11. Das A., Long E.O. Lytic granule polarization, rather than degranulation, is the preferred target of inhibitory receptors in NK cells. J Immunol 2010, 185:4698-4704.
12. Carbone E., Terrazzano G., Colonna M., Tuosto L., Piccolella E., Franksson L., et al. Natural killer clones recognize specific soluble HLA class I molecules. Eur J Immunol 1996, 26:683-689.
13. Campoli M., Ferrone S. Tumor escape mechanisms: potential role of soluble HLA antigens and NK cells activating ligands. Tissue Antigens 2008, 72:321-334.
14. Takahashi K., Sawasaki Y., Hata J., Mukai K., Goto T. Spontaneous transformation and immortalization of human endothelial cells. In Vitro Cell Dev Biol 1990, 26:265-274.
15. Brown J., Reading S.J., Jones S., Fitchett C.J., Howl J., Martin A., et al. Critical evaluation of ECV304 as a human endothelial cell model defined by genetic analysis and functional responses: a comparison with the human bladder cancer derived epithelial cell line T24/83. Lab Invest 2000, 80:37-45.
16. Wilhelm I., Fazakas C., Krizbai I.A. In vitro models of the blood-brain barrier. Acta Neurobiol Exp (Wars) 2011, 71:113-128.
17. Untucht C., Rasch J., Fuchs E., Rohde M., Bergmann S., Steinert M. An optimized in vitro blood-brain barrier model reveals bidirectional transmigration of African trypanosome strains. Microbiology 2011, 157:2933-2941.
18. Abraham S., Nagaraj A.S., Basak S., Manjunath R. Japanese encephalitis virus utilizes the canonical pathway to activate NF-kappaB but it utilizes the type I interferon pathway to induce major histocompatibility complex class I expression in mouse embryonic fibroblasts. J Virol 2010, 84:5485-5493.
19. Palmisano G.L., Contardi E., Morabito A., Gargaglione V., Ferrara G.B., Pistillo M.P. HLA-E surface expression is independent of the availability of HLA class I signal sequence-derived peptides in human tumor cell lines. Hum Immunol 2005, 66:1-12.
20. Menier C., Saez B., Horejsi V., Martinozzi S., Krawice-Radanne I., Bruel S., et al. Characterization of monoclonal antibodies recognizing HLA-G or HLA-E: new tools to analyze the expression of nonclassical HLA class I molecules. Hum Immunol 2003, 64:315-326.
21. Robertson M.J., Cochran K.J., Cameron C., Le J.M., Tantravahi R., Ritz J. Characterization of a cell line, NKL, derived from an aggressive human natural killer cell leukemia. Exp Hematol 1996, 24:406-415.
22. Tabayoyong W.B., Zavazava N. Soluble HLA revisited. Leuk Res 2007, 31:121-125.
23. Ravindranath M.H., Taniguchi M., Chen C.W., Ozawa M., Kaneku H., El-Awar N., et al. HLA-E monoclonal antibodies recognize shared peptide sequences on classical HLA class Ia: relevance to human natural HLA antibodies. Mol Immunol 2010, 47:1121-1131.
24. Braud V.M., Aldemir H., Breart B., Ferlin W.G. Expression of CD94-NKG2A inhibitory receptor is restricted to a subset of CD8+ T cells. Trends Immunol 2003, 24:162-164.
25. Le Drean E., Vely F., Olcese L., Cambiaggi A., Guia S., Krystal G., et al. Inhibition of antigen-induced T cell response and antibody-induced NK cell cytotoxicity by NKG2A: association of NKG2A with SHP-1 and SHP-2 protein-tyrosine phosphatases. Eur J Immunol 1998, 28:264-276.
26. Lee N., Llano M., Carretero M., Ishitani A., Navarro F., Lopez-Botet M., et al. HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A. Proc Natl Acad Sci USA 1998, 95:5199-5204.
27. Tsuchiya N., Shiota M., Yamaguchi A., Ito K. Elevated serum level of soluble HLA class I antigens in patients with systemic lupus erythematosus. Arthritis Rheum 1996, 39:792-796.
28. Contini P., Ghio M., Poggi A., Filaci G., Indiveri F., Ferrone S., et al. Soluble HLA-A,-B,-C and -G molecules induce apoptosis in T and NK CD8+ cells and inhibit cytotoxic T cell activity through CD8 ligation. Eur J Immunol 2003, 33:125-134.
29. Derre L., Corvaisier M., Charreau B., Moreau A., Godefroy E., Moreau-Aubry A., et al. Expression and release of HLA-E by melanoma cells and melanocytes: potential impact on the response of cytotoxic effector cells. J Immunol 2006, 177:3100-3107.
30. Coupel S., Moreau A., Hamidou M., Horejsi V., Soulillou J.P., Charreau B. Expression and release of soluble HLA-E is an immunoregulatory feature of endothelial cell activation. Blood 2007, 109:2806-2814.
31. Vitale M., Matteucci A., Manzoli L., Rodella L., Mariani A.R., Zauli G., et al. Interleukin 2 activates nuclear phospholipase Cbeta by mitogen-activated protein kinase-dependent phosphorylation in human natural killer cells. FASEB J 2001, 15:1789-1791.
32. Zingoni A., Palmieri G., Morrone S., Carretero M., Lopez-Botel M., Piccoli M., et al. CD69-triggered ERK activation and functions are negatively regulated by CD94/NKG2-A inhibitory receptor. Eur J Immunol 2000, 30:644-651.
33. Cheng M., Zhang J., Jiang W., Chen Y., Tian Z. Natural killer cell lines in tumor immunotherapy. Front Med 2012, 6:56-66.
34. Tomasec P., Braud V.M., Rickards C., Powell M.B., McSharry B.P., Gadola S., et al. Surface expression of HLA-E, an inhibitor of natural killer cells, enhanced by human cytomegalovirus gpUL40. Science 2000, 287:1031-1033.
35. Orange J.S., Fassett M.S., Koopman L.A., Boyson J.E., Strominger J.L. Viral evasion of natural killer cells. Nat Immunol 2002, 3:1006-1012.
36. Chang L., Karin M. Mammalian MAP kinase signalling cascades. Nature 2001, 410:37-40.